Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201208046 Principal Investigator: Vij, Ravi
Title: A Phase II Study of V-BEAM (Bortezomib, Carmustine, Etoposide, Cytarabine, and Melphalan) as Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation for Multiple Myeloma
Phase: II Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see if the combination of bortezomib added to the drug regimen BEAM will be an effective treatment.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)